Lomerizine

DB14065

small molecule experimental

Deskripsi

Lomerizine is a diphenylmethylpiperazine calcium channel blockerA245378, A245383 with relatively selective central nervous system (CNS) effects.A245383
This drug is used to prophylactically treat migrainesA245368, A245373 and is also being investigated against eye-related diseases that are associated with local circulatory disturbances, an example being normal-tension glaucoma.A245378

Struktur Molekul 2D

Berat 468.545
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

756 Data
Ceritinib Lomerizine may increase the bradycardic activities of Ceritinib.
Ivabradine Lomerizine may increase the bradycardic activities of Ivabradine.
Ruxolitinib Ruxolitinib may increase the bradycardic activities of Lomerizine.
Cimetidine The serum concentration of Lomerizine can be increased when it is combined with Cimetidine.
Clopidogrel The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Lomerizine.
Efavirenz The serum concentration of Lomerizine can be decreased when it is combined with Efavirenz.
Melatonin The therapeutic efficacy of Lomerizine can be decreased when used in combination with Melatonin.
Nafcillin The therapeutic efficacy of Lomerizine can be decreased when used in combination with Nafcillin.
Nitroprusside Lomerizine may increase the hypotensive activities of Nitroprusside.
Dantrolene The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Lomerizine.
Lithium citrate The risk or severity of adverse effects can be increased when Lomerizine is combined with Lithium citrate.
Lithium carbonate The risk or severity of adverse effects can be increased when Lomerizine is combined with Lithium carbonate.
Lithium hydroxide The risk or severity of adverse effects can be increased when Lomerizine is combined with Lithium hydroxide.
Boceprevir The serum concentration of Lomerizine can be increased when it is combined with Boceprevir.
Ibutilide Ibutilide may increase the arrhythmogenic activities of Lomerizine.
Hyoscyamine Hyoscyamine may increase the arrhythmogenic activities of Lomerizine.
Atropine Atropine may increase the arrhythmogenic activities of Lomerizine.
Adenosine Adenosine may increase the arrhythmogenic activities of Lomerizine.
Moricizine Moricizine may increase the arrhythmogenic activities of Lomerizine.
Levosimendan Levosimendan may increase the arrhythmogenic activities of Lomerizine.
Procainamide Procainamide may increase the arrhythmogenic activities of Lomerizine.
Tocainide Tocainide may increase the arrhythmogenic activities of Lomerizine.
Flecainide Flecainide may increase the arrhythmogenic activities of Lomerizine.
Encainide Encainide may increase the arrhythmogenic activities of Lomerizine.
Ajmaline Ajmaline may increase the arrhythmogenic activities of Lomerizine.
Aprindine Aprindine may increase the arrhythmogenic activities of Lomerizine.
Azimilide Azimilide may increase the arrhythmogenic activities of Lomerizine.
Tedisamil Tedisamil may increase the arrhythmogenic activities of Lomerizine.
Vernakalant Vernakalant may increase the arrhythmogenic activities of Lomerizine.
Cariporide Cariporide may increase the arrhythmogenic activities of Lomerizine.
Xylometazoline Xylometazoline may increase the arrhythmogenic activities of Lomerizine.
Sparteine Sparteine may increase the arrhythmogenic activities of Lomerizine.
Fasudil Fasudil may increase the arrhythmogenic activities of Lomerizine.
Melperone Melperone may increase the arrhythmogenic activities of Lomerizine.
Tropisetron Tropisetron may increase the arrhythmogenic activities of Lomerizine.
Simendan Simendan may increase the arrhythmogenic activities of Lomerizine.
Spiradoline Spiradoline may increase the arrhythmogenic activities of Lomerizine.
Pilsicainide Pilsicainide may increase the arrhythmogenic activities of Lomerizine.
Cicletanine Cicletanine may increase the arrhythmogenic activities of Lomerizine.
Cibenzoline Cibenzoline may increase the arrhythmogenic activities of Lomerizine.
Nizofenone Nizofenone may increase the arrhythmogenic activities of Lomerizine.
Prajmaline Prajmaline may increase the arrhythmogenic activities of Lomerizine.
Tiracizine Tiracizine may increase the arrhythmogenic activities of Lomerizine.
Ethacizine Ethacizine may increase the arrhythmogenic activities of Lomerizine.
Lorajmine Lorajmine may increase the arrhythmogenic activities of Lomerizine.
Bunaftine Bunaftine may increase the arrhythmogenic activities of Lomerizine.
Lorcainide Lorcainide may increase the arrhythmogenic activities of Lomerizine.
Hydroquinine Hydroquinine may increase the arrhythmogenic activities of Lomerizine.
Fosfructose Fosfructose may increase the arrhythmogenic activities of Lomerizine.
Carteolol Lomerizine may increase the arrhythmogenic activities of Carteolol.
Metipranolol Lomerizine may increase the arrhythmogenic activities of Metipranolol.
Bioallethrin Lomerizine may increase the arrhythmogenic activities of Bioallethrin.
Hydroquinidine Lomerizine may increase the arrhythmogenic activities of Hydroquinidine.
SOR-C13 Lomerizine may increase the arrhythmogenic activities of SOR-C13.
Acetyldigitoxin Acetyldigitoxin may increase the arrhythmogenic activities of Lomerizine.
Deslanoside Deslanoside may increase the arrhythmogenic activities of Lomerizine.
Cymarin Cymarin may increase the arrhythmogenic activities of Lomerizine.
Niguldipine Niguldipine may increase the arrhythmogenic activities of Lomerizine.
Bretylium Bretylium may increase the arrhythmogenic activities of Lomerizine.
Isradipine Isradipine may increase the arrhythmogenic activities of Lomerizine.
Trimethadione Trimethadione may increase the arrhythmogenic activities of Lomerizine.
Amlodipine Amlodipine may increase the arrhythmogenic activities of Lomerizine.
Nimodipine Nimodipine may increase the arrhythmogenic activities of Lomerizine.
Lercanidipine Lercanidipine may increase the arrhythmogenic activities of Lomerizine.
Cinnarizine Cinnarizine may increase the arrhythmogenic activities of Lomerizine.
Levomenthol Levomenthol may increase the arrhythmogenic activities of Lomerizine.
Zonisamide Zonisamide may increase the arrhythmogenic activities of Lomerizine.
Nitrendipine Nitrendipine may increase the arrhythmogenic activities of Lomerizine.
Perhexiline Perhexiline may increase the arrhythmogenic activities of Lomerizine.
Bepridil Bepridil may increase the arrhythmogenic activities of Lomerizine.
Nimesulide Nimesulide may increase the arrhythmogenic activities of Lomerizine.
Prenylamine Prenylamine may increase the arrhythmogenic activities of Lomerizine.
Cyclandelate Cyclandelate may increase the arrhythmogenic activities of Lomerizine.
Flunarizine Flunarizine may increase the arrhythmogenic activities of Lomerizine.
Fluspirilene Fluspirilene may increase the arrhythmogenic activities of Lomerizine.
Clevidipine Clevidipine may increase the arrhythmogenic activities of Lomerizine.
Methsuximide Methsuximide may increase the arrhythmogenic activities of Lomerizine.
Seletracetam Seletracetam may increase the arrhythmogenic activities of Lomerizine.
Nylidrin Nylidrin may increase the arrhythmogenic activities of Lomerizine.
Ziconotide Ziconotide may increase the arrhythmogenic activities of Lomerizine.
Dotarizine Dotarizine may increase the arrhythmogenic activities of Lomerizine.
Nilvadipine Nilvadipine may increase the arrhythmogenic activities of Lomerizine.
Tranilast Tranilast may increase the arrhythmogenic activities of Lomerizine.
Agmatine Agmatine may increase the arrhythmogenic activities of Lomerizine.
Fendiline Fendiline may increase the arrhythmogenic activities of Lomerizine.
Eperisone Eperisone may increase the arrhythmogenic activities of Lomerizine.
Trimebutine Trimebutine may increase the arrhythmogenic activities of Lomerizine.
Pinaverium Pinaverium may increase the arrhythmogenic activities of Lomerizine.
Nicorandil Nicorandil may increase the arrhythmogenic activities of Lomerizine.
Barnidipine Barnidipine may increase the arrhythmogenic activities of Lomerizine.
Aranidipine Aranidipine may increase the arrhythmogenic activities of Lomerizine.
Azelnidipine Azelnidipine may increase the arrhythmogenic activities of Lomerizine.
Benidipine Benidipine may increase the arrhythmogenic activities of Lomerizine.
Cilnidipine Cilnidipine may increase the arrhythmogenic activities of Lomerizine.
Darodipine Darodipine may increase the arrhythmogenic activities of Lomerizine.
Efonidipine Efonidipine may increase the arrhythmogenic activities of Lomerizine.
Lacidipine Lacidipine may increase the arrhythmogenic activities of Lomerizine.
Manidipine Manidipine may increase the arrhythmogenic activities of Lomerizine.
Niludipine Niludipine may increase the arrhythmogenic activities of Lomerizine.
Carboxyamidotriazole Carboxyamidotriazole may increase the arrhythmogenic activities of Lomerizine.

Target Protein

Sodium channel protein type 5 subunit alpha SCN5A
Voltage-dependent N-type calcium channel subunit alpha-1B CACNA1B
ATP-dependent translocase ABCB1 ABCB1

Referensi & Sumber

Artikel (PubMed)
  • PMID: 21656126
    Ishii M, Iizuka R, Kiuchi Y, Mori Y, Shimizu S: Neuroprotection by lomerizine, a prophylactic drug for migraine, against hydrogen peroxide-induced hippocampal neurotoxicity. Mol Cell Biochem. 2011 Dec;358(1-2):1-11. doi: 10.1007/s11010-011-0913-3. Epub 2011 Jun 9.
  • PMID: 19783864
    Ishii M, Kobayashi S, Ohkura M, Yamamoto R, Shimizu S, Kiuchi Y: Inhibitory effect of lomerizine, a prophylactic drug for migraines, on serotonin-induced contraction of the basilar artery. J Pharmacol Sci. 2009 Oct;111(2):221-5. doi: 10.1254/jphs.09205sc. Epub 2009 Sep 26.
  • PMID: 11324981
    Toriu N, Sasaoka M, Shimazawa M, Sugiyama T, Hara H: Effects of lomerizine, a novel Ca2+ channel blocker, on the normal and endothelin-1-disturbed circulation in the optic nerve head of rabbits. J Ocul Pharmacol Ther. 2001 Apr;17(2):131-49. doi: 10.1089/10807680151125456.
  • PMID: 19913075
    Selt M, Bartlett CA, Harvey AR, Dunlop SA, Fitzgerald M: Limited restoration of visual function after partial optic nerve injury; a time course study using the calcium channel blocker lomerizine. Brain Res Bull. 2010 Mar 16;81(4-5):467-71. doi: 10.1016/j.brainresbull.2009.11.004. Epub 2009 Nov 11.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul